148 results

... clinical trials are required.[ 138 , 139 ] Management and Prevention of Myeloma Bone Disease Myeloma bone disease is ... Patients who received the selinexor combination had more thrombocytopenia (39% vs. 17%) and fatigue (13% vs. 1%). ...

... from infections. GATA1 -related cytopenia is characterized by thrombocytopenia and/or anemia ranging from mild to severe. Thrombocytopenia typically presents in infancy as a bleeding disorder ...

... disorder immune system modulator immune system tolerance immune thrombocytopenia immune thrombocytopenic purpura immunity immunization immunoassay immunoassay fecal ...

... is usually only required for the treatment or prevention of severe bleeding episodes ... of any thrombocytopenia. Individuals with mild or atypical type 2B VWD ( ...

... in the ongoing management of both conditions. 80 Prevention and Treatment Approaches High-quality prenatal care aims ...

... augmentation procedures may be necessary before implant placement. Prevention of Secondary Complications It is recommended that individuals ... den Boogaard MJ. Concurrent manifestation of oligodontia and thrombocytopenia caused by a contiguous gene deletion in 12p13. ...

... HLH = hemophagocytic lymphohistiocytosis; HSCT = hematopoietic stem cell transplantation Prevention of Primary Manifestations Antibacterial prophylaxis. No randomized prospective ...

... Huemer et al 2005 , Trefz et al 2016 ]. Prevention of Primary Manifestations Early institution of injectable hydroxocobalamin ... be treated with glucose-containing IV fluid. Flu prevention (i.e., immunization) should be a routine part ...

... anemia, it can also result in leukopenia and thrombocytopenia, which may be associated with significant bleeding [ Pain ... secondary to hemolysis and can also lead to thrombocytopenia and leukopenia. In addition, porphyrin deposition also occurs ...

... 46% vs. 13%), anemia (35% vs. 5%), and thrombocytopenia (33% vs. <1%). Evidence (doxorubicin and trabectedin vs. ... neutropenia (80% vs. 13%), anemia (31% vs. 5%), thrombocytopenia (35% vs. 0%), and febrile neutropenia (28% vs. ...